554 related articles for article (PubMed ID: 15528017)
1. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
[TBL] [Abstract][Full Text] [Related]
2. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Clin Lab Med; 2005 Mar; 25(1):39-59. PubMed ID: 15749231
[TBL] [Abstract][Full Text] [Related]
3. The course of genetically determined chronic pancreatitis.
Keim V; Witt H; Bauer N; Bodeker H; Rosendahl J; Teich N; Mossner J
JOP; 2003 Jul; 4(4):146-54. PubMed ID: 12853682
[TBL] [Abstract][Full Text] [Related]
4. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.
Bernardino AL; Guarita DR; Mott CB; Pedroso MR; Machado MC; Laudanna AA; Tani CM; Almeida FL; Zatz M
JOP; 2003 Sep; 4(5):169-77. PubMed ID: 14526128
[TBL] [Abstract][Full Text] [Related]
5. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
[TBL] [Abstract][Full Text] [Related]
6. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
Chandak GR; Idris MM; Reddy DN; Mani KR; Bhaskar S; Rao GV; Singh L
Gut; 2004 May; 53(5):723-8. PubMed ID: 15082592
[TBL] [Abstract][Full Text] [Related]
7. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications.
Truninger K; Ammann RW; Blum HE; Witt H
Swiss Med Wkly; 2001 Oct; 131(39-40):565-74. PubMed ID: 11775491
[TBL] [Abstract][Full Text] [Related]
8. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
Keiles S; Kammesheidt A
Pancreas; 2006 Oct; 33(3):221-7. PubMed ID: 17003641
[TBL] [Abstract][Full Text] [Related]
9. Hereditary chronic pancreatitis.
Teich N; Mössner J
Best Pract Res Clin Gastroenterol; 2008; 22(1):115-30. PubMed ID: 18206817
[TBL] [Abstract][Full Text] [Related]
10. Novel mutation and polymorphism of PRSS1 gene in the Chinese patients with hereditary pancreatitis and chronic pancreatitis.
Liu QC; Gao F; Ou QS; Zhuang ZH; Lin SR; Yang B; Cheng ZJ
Chin Med J (Engl); 2008 Jan; 121(2):108-11. PubMed ID: 18272034
[TBL] [Abstract][Full Text] [Related]
11. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
12. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families.
Grocock CJ; Rebours V; Delhaye MN; Andrén-Sandberg A; Weiss FU; Mountford R; Harcus MJ; Niemczyck E; Vitone LJ; Dodd S; Jørgensen MT; Ammann RW; Schaffalitzky de Muckadell O; Butler JV; Burgess P; Kerr B; Charnley R; Sutton R; Raraty MG; Devière J; Whitcomb DC; Neoptolemos JP; Lévy P; Lerch MM; Greenhalf W;
Gut; 2010 Mar; 59(3):357-63. PubMed ID: 19951905
[TBL] [Abstract][Full Text] [Related]
13. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site.
Felderbauer P; Schnekenburger J; Lebert R; Bulut K; Parry M; Meister T; Schick V; Schmitz F; Domschke W; Schmidt WE
J Med Genet; 2008 Aug; 45(8):507-12. PubMed ID: 18511571
[TBL] [Abstract][Full Text] [Related]
14. Hereditary pancreatitis: clinical features and inheritance characteristics of the R122C mutation in the cationic trypsinogen gene (PRSS1) in six Spanish families.
de las Heras-Castaño G; Castro-Senosiaín B; Fontalba A; López-Hoyos M; Sánchez-Juán P
JOP; 2009 May; 10(3):249-55. PubMed ID: 19454815
[TBL] [Abstract][Full Text] [Related]
15. Genetic counseling for hereditary pancreatitis--the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1.
Ellis I
Gastroenterol Clin North Am; 2004 Dec; 33(4):839-54. PubMed ID: 15528021
[TBL] [Abstract][Full Text] [Related]
16. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
[TBL] [Abstract][Full Text] [Related]
17. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.
Drenth JP; te Morsche R; Jansen JB
Gut; 2002 May; 50(5):687-92. PubMed ID: 11950817
[TBL] [Abstract][Full Text] [Related]
18. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.
Teich N; Bauer N; Mössner J; Keim V
Am J Gastroenterol; 2002 Feb; 97(2):341-6. PubMed ID: 11866271
[TBL] [Abstract][Full Text] [Related]
19. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
Sobczyńska-Tomaszewska A; Bak D; Oralewska B; Oracz G; Norek A; Czerska K; Mazurczak T; Teisseyre M; Socha J; Zagulski M; Bal J
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):299-306. PubMed ID: 16954950
[TBL] [Abstract][Full Text] [Related]
20. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.
Audrézet MP; Chen JM; Le Maréchal C; Ruszniewski P; Robaszkiewicz M; Raguénès O; Quéré I; Scotet V; Férec C
Eur J Hum Genet; 2002 Feb; 10(2):100-6. PubMed ID: 11938439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
